← Back to Search

Natural History Study for Retinitis Pigmentosa (PHENOROD2 Trial)

N/A
Waitlist Available
Led By Saddek Mohand-Saïd, MD, PhD
Research Sponsored by SparingVision
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
RP with mutations affecting the RHO, PDE6A and PDE6B genes
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

PHENOROD2 Trial Summary

This trial is looking at the effects of different mutations that cause Retinitis Pigmentosa, a degenerative disease of the retina.

Who is the study for?
This study is for individuals with Retinitis Pigmentosa, a degenerative eye condition, specifically caused by mutations in the RHO, PDE6A or PDE6B genes. Participants must have a certain level of visual acuity and field diameter, understand the local language well enough to follow instructions, and be part of a health system if they're in France. Pregnant women or those with other retinal issues are excluded.Check my eligibility
What is being tested?
The trial involves regular eye exams and mobility tests to track how Retinitis Pigmentosa progresses over time when it's caused by specific genetic mutations. It's an observational study meaning there's no treatment being tested; instead, researchers are studying the natural course of the disease.See study design
What are the potential side effects?
Since this is an observational study without any medical treatments or drugs being administered, there are no direct side effects from interventions. However, participants may experience discomfort from frequent ophthalmic examinations.

PHENOROD2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My retinitis pigmentosa is due to mutations in RHO, PDE6A, or PDE6B genes.

PHENOROD2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fundus Autofluorescence (FAF)
Spectral Domain Optical Coherence tomography (SD-OCT)
Secondary outcome measures
Color vision
Dark adaptometry (DA)
Full-field stimulus threshold (FST)
+2 more

PHENOROD2 Trial Design

2Treatment groups
Experimental Treatment
Group I: Study Group 2Experimental Treatment2 Interventions
Four years follow-up of patients with ophthalmic examination and mobility testing.
Group II: Study Group 1Experimental Treatment1 Intervention
Four years follow up of patients with ophthalmic examination.

Find a Location

Who is running the clinical trial?

SparingVisionLead Sponsor
2 Previous Clinical Trials
146 Total Patients Enrolled
2 Trials studying Retinitis Pigmentosa
146 Patients Enrolled for Retinitis Pigmentosa
Saddek Mohand-Saïd, MD, PhDPrincipal InvestigatorCHNO XV-XX Paris - CIC 1423
Isabelle Audo, MD, PhDPrincipal InvestigatorCHNO XV-XX Paris - CIC 1423

Media Library

Study Group 1 Clinical Trial Eligibility Overview. Trial Name: NCT04285398 — N/A
Retinitis Pigmentosa Research Study Groups: Study Group 1, Study Group 2
Retinitis Pigmentosa Clinical Trial 2023: Study Group 1 Highlights & Side Effects. Trial Name: NCT04285398 — N/A
Study Group 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT04285398 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What ultimate goal is this medical research aiming to attain?

"This clinical study, lasting approximately 12 months, will measure the progression of disease over time through Fundus Autofluorescence (FAF), Dark Adaptometry (DA) refraction and visual acuity using ETDRS or Snellen scales as well as Full-field Stimulus Thresholds (FST)."

Answered by AI

Is this experiment still recruiting participants?

"According to clinicaltrials.gov, this particular medical study is not currently recruiting participants; the trial was initially posted on February 12th 2020 and last updated on April 19th 2022. Despite this fact, there are 51 other research initiatives that are actively enrolling patients at present."

Answered by AI

Who else is applying?

What site did they apply to?
UPMC Eye Center
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Average response time
  • < 1 Day
Typically responds via
Phone Call
Most responsive sites:
  1. UPMC Eye Center: < 24 hours
Recent research and studies
clinicaltrials.govStudy
Prospective Natural History Study of Retinitis Pigmentosa
2020. "Prospective Natural History Study of Retinitis Pigmentosa". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04285398.
All > Retinitis Pigmentosa
~28 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top